6533b85efe1ef96bd12bfd0a
RESEARCH PRODUCT
Mast cells and the development of allergic airway disease
Christian TaubeSebastian Reutersubject
Lungbusiness.industryLeukotriene B4EffectorAirway inflammationPublic Health Environmental and Occupational HealthReviewrespiratory systemToxicologyrespiratory tract diseaseschemistry.chemical_compoundmedicine.anatomical_structureAirway diseasechemistryImmunologymedicineTumor necrosis factor alphabusinessSafety ResearchSensitizationHistaminedescription
Murine models have highlighted the importance of T-cells and TH2 cytokines in development of allergen-induced airway disease. In contrast, the role of mast cells for the development of allergic airway disease has been controversial. Recent studies in murine models demonstrate a significant contribution of mast cells during the development of airway hyperresponsiveness and airway inflammation. Furthermore these models have allowed identifying certain mast cell-produced mediators (e.g. histamine and leukotriene B4) to be involved in the recruitment of effector T-cells into the lung. Additionally, mast cell-produced TNF can directly activate TH2 cells and contribute to the development of allergic airway disease. These new findings demonstrate a complex role of mast cells and their mediators, not only as effector cells, but also during sensitization and development of allergic airway disease. Therefore mast cells and certain mast cell-produced mediators might be an interesting target for the prevention and treatment of allergic asthma.
year | journal | country | edition | language |
---|---|---|---|---|
2008-03-05 | Journal of Occupational Medicine and Toxicology |